BNP Paribas Financial Markets
XERS icon

BNP Paribas Financial Markets’s Xeris Biopharma Holdings XERS Stock Holding History

BNP Paribas Financial Markets’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.52M Buy
262,787
+4,419
+2% +$29.3K ﹤0.01% 2841
2025
Q4 		$2.03M Sell
258,368
-323,351
-56% -$2.54M ﹤0.01% 2606
2025
Q3 		$4.74M Buy
581,719
+565,409
+3,467% +$3.76M ﹤0.01% 2019
2025
Q2 		$76.2K Sell
16,310
-328,578
-95% -$1.51M ﹤0.01% 4102
2025
Q1 		$1.89M Buy
344,888
+244,876
+245% +$988K ﹤0.01% 2398
2024
Q4 		$339K Buy
+100,012
New +$322K ﹤0.01% 3547
2021
Q4 		– Sell
-1,118
Closed -$2.74K – 4281
2021
Q3 		$2.74K Sell
1,118
-700
-39% -$2.03K ﹤0.01% 3763
2021
Q2 		$7.4K Sell
1,818
-4,182
-70% -$16K ﹤0.01% 3774
2021
Q1 		$27.1K Sell
6,000
-3,150
-34% -$17K ﹤0.01% 3715
2020
Q4 		$45K Sell
9,150
-1,935
-17% -$9.68K ﹤0.01% 3605
2020
Q3 		$65.7K Buy
11,085
+8,181
+282% +$32.7K ﹤0.01% 3335
2020
Q2 		$7.72K Sell
2,904
-6,330
-69% -$22K ﹤0.01% 3820
2020
Q1 		$18K Buy
9,234
+6,162
+201% +$26.5K ﹤0.01% 3928
2019
Q4 		$21.7K Sell
3,072
-483
-14% -$3.99K ﹤0.01% 3978
2019
Q3 		$34.9K Buy
3,555
+1,242
+54% +$14K ﹤0.01% 3677
2019
Q2 		$26.5K Sell
2,313
-1,974
-46% -$20.7K ﹤0.01% 3795
2019
Q1 		$43K Buy
+4,287
New +$54.9K ﹤0.01% 3589

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets's XERS Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Xeris Biopharma Holdings (XERS) stake by 1.7% in Q1 2026, buying an estimated $29.3K and bringing the position to 262,787 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2841.

BNP Paribas Financial Markets first reported a position in XERS in Q1 2019 and has held it in 17 quarters since. The position peaked at $4.74M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • BNP Paribas Financial Markets held 262,787 shares of Xeris Biopharma Holdings worth $1.52M as of Q1 2026.
  • BNP Paribas Financial Markets bought 4,419 Xeris Biopharma Holdings shares in Q1 2026, an estimated $29.3K.
  • Xeris Biopharma Holdings made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #2841 holding.
  • BNP Paribas Financial Markets first reported a position in Xeris Biopharma Holdings in Q1 2019 and has held it in 17 quarters since.
  • BNP Paribas Financial Markets's Xeris Biopharma Holdings position peaked at $4.74M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.